MenAfriVac Helps Move Africa’s Sahel Toward Meningitis Elimination

Humanosphere: Vaccine on track to eliminate one of Africa’s most feared and deadly diseases — meningitis
Tom Paulson, founder and lead journalist at Humanosphere, discusses progress toward eliminating meningitis in Africa’s Sahel region through the use of the MenAfriVac vaccine, which the WHO recently approved for use in infants (1/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.